Octiveran (Tenoxicam)

Tenoxicam, the active ingredient in Octiveran, is a non‑steroidal anti‑inflammatory drug presented as a 20 mg tablet for oral use. It is indicated for the short‑term management of pain and inflammation associated with musculoskeletal disorders in adults.

GNH USA supplies Octiveran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Octiveran (tenoxicam) is employed in conditions that involve inflammatory pain pathways, particularly within the musculoskeletal system. - Rheumatoid arthritis: reduces joint pain, swelling and stiffness. - Osteoarthritis: alleviates chronic joint discomfort and improves mobility. - Ankylosing spondylitis: diminishes spinal inflammation and associated pain. - Acute musculoskeletal injury: provides short‑term relief of pain and inflammation. - Post‑operative pain: assists in managing postoperative inflammatory pain.

Adverse reactions to tenoxicam may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastro‑intestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient episodes of light‑headedness. - Skin rash: mild erythema or pruritus. - Elevated liver enzymes: mild, reversible changes in hepatic function tests.

Serious or Rare Side Effects: - Gastro‑intestinal ulceration or bleeding: may present with hematemesis or melena. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: sudden rise in serum creatinine or reduced urine output. - Hepatotoxicity: marked elevation of transaminases or jaundice. - Anaphylaxis: acute, potentially life‑threatening hypersensitivity reaction.

Before initiating therapy with Octiveran, consider the following safety measures: - Renal function assessment: evaluate baseline kidney function, especially in patients with chronic kidney disease. - Hepatic monitoring: check liver enzymes prior to treatment and periodically thereafter. - Gastro‑intestinal risk: assess history of ulcers, bleeding or concurrent NSAID/anticoagulant use. - Cardiovascular caution: use cautiously in patients with hypertension, heart failure or prior thrombotic events. - Concomitant medications: review all current drugs for potential interactions. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Tenoxicam can interact with several drug classes, altering efficacy or safety profiles.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - High‑dose aspirin: additive ulcerogenic effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce antihypertensive response and affect renal function. - Diuretics (loop or thiazide): potential for decreased renal perfusion. - Lithium: NSAIDs can raise serum lithium levels, risking toxicity.